Tactile Systems Technology (TCMD)
(Delayed Data from NSDQ)
$14.17 USD
-0.07 (-0.49%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $14.21 +0.04 (0.28%) 7:58 PM ET
3-Hold of 5 3
A Value A Growth C Momentum A VGM
Price, Consensus and EPS Surprise
TCMD 14.17 -0.07(-0.49%)
Will TCMD be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for TCMD based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for TCMD
Implied Volatility Surging for Tactile Systems (TCMD) Stock Options
Tactile Medical's Shares Rise After PDAC Approval for Nimbl
TCMD: What are Zacks experts saying now?
Zacks Private Portfolio Services
Does Tactile Systems Technology (TCMD) Have the Potential to Rally 57.31% as Wall Street Analysts Expect?
Should Value Investors Buy Tactile Systems Technology (TCMD) Stock?
Tactile Systems Technology (TCMD) Recently Broke Out Above the 20-Day Moving Average
Other News for TCMD
Tactile Medical Receives PDAC Approval for Nimbl? Lymphedema Platform
Tactile Systems receives PDAC approval for Nimbl
Tactile Systems Technology Breaks Above 200-Day Moving Average - Bullish for TCMD
Analysts Offer Insights on Healthcare Companies: Ginkgo Bioworks Holdings (DNA), BioMarin Pharmaceutical (BMRN) and Tactile Systems Technology (TCMD)
TCMD Makes Bullish Cross Above Critical Moving Average